Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hiab Corporation - Managers' transactions - Sra
-
Hiab Corporation - Managers' transactions - Sotamaa
-
Hiab Corporation - Managers' transactions - Pohjolainen-Hiltunen
-
Hiab Corporation - Managers' transactions - Moisio
-
Hiab Corporation - Managers' transactions - Lindholm
-
Hiab Corporation - Managers' transactions - Herlin
-
Hiab Corporation - Managers' transactions - Hankonen-Nybom
-
Hiab Corporation - Managers' transactions - Alström
-
Marimekko Day on 16 May at Esplanade Park – Featuring Artist Goldielocks
-
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
-
Progress on share buyback programme
-
Invitation to Enefit Green investor webinars presenting Q1 2025 interim results
-
Elis: Disclosure of trading in own shares occured from April 28 to May 2, 2025
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
Appointment of Nominated & Financial Adviser
-
Transaction in Own Shares
-
Transactions Made Under the Share Buy-back Programme for Stolt-Nielsen Limited
-
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
-
Three-month interim report (Q1) 2025 (unaudited)
-
Q1 2025 INTERIM REPORT - 2025-TRANSITION PROGRESSING
-
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
-
International Petroleum Corporation Announces First Quarter 2025 Financial and Operational Results
-
Report for the three months ended 31 March 2025
-
Inbank unaudited financial results for Q1 2025
-
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
-
BW Offshore: 2025 Annual General Meeting – Notice
-
Viridien secures sale of Sercel Marlin Offshore Logistics solution to ONGC
-
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Philips delivers on Q1 results, with ongoing order intake growth
-
KH Group Plc’s Business Review January–March 2025: Moderate growth and improving profitability
-
Start of Day Message
-
Hexagon Purus ASA: Results for the first quarter 2025
-
Steady course in turbulent times
-
26/2025・Trifork Group: Interim report for the quarter ending 31 March 2025
-
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Dividend Payments Ex-date of AS Tallinna Sadam
-
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
-
argenx to Present at BofA Securities 2025 Health Care Conference
-
The 33rd China Cycle 2025 Grandly Commence
-
EfTEN United Property Fund unaudited financial results for 1st quarter of 2025
-
CORRECTION – Titanium Transportation Group Will Hold a Conference Call to Discuss its First Quarter Results
-
Aquaron Announces Postponement of Annual Meeting
-
DMG Blockchain Solutions Announces Preliminary April Operational Results
-
Grupo Aeroportuario Del Pacifico Announces Debt Securities “GAP 21” Payment
-
UPCX Staking Airdrop (May 2025): Building the Future of Payments with the Community
-
Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
-
EVDANCE Launches Pre-Sale for New FLUX 40A Smart EV Charger with App – 30% Off for a Limited Time!
-
Discovery Files Final Base Shelf Prospectus
-
Aura Declares Dividend of US$0.40 per share and US$0.1333 per BDR based on Q1 2025 Results, resulting in a Dividend Yield of 11%¹ in the LTM

